KALA

NASD KALA BIO, Inc.
Oct 3, 2026 · 11:34 AM ET EOD Market Closed

$0.3850 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3850, $0.0350 below the day’s high of $0.4200

YTD change
-98.61%
vs 20-day SMA
-26.87%
vs 200-day SMA
-96.14%

Price ranges

Previous day
$0.3803 $0.4200
open $0.4100 close $0.3850
-$0.0250 (-6.10%)
Today
$0.3803 $0.4200
$0.3850
Past week
$0.4010 $0.5600
from $0.5600 now $0.3850
-$0.1750 (-31.25%)
Past month
$0.4010 $0.6118
from $0.5225 now $0.3850
-$0.1375 (-26.32%)
This year
$0.0660 $27.7950
from $27.7950 now $0.3850
-$27.4100 (-98.61%)

Price & Performance

+0.21 (+122.67%) / 6M

$-0.2272$1.25$2.74$4.22Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $66,875.0000
  • KALA is down 99% since the beginning of the year
  • KALA is down 99% over the past 12 months
  • KALA is down 26% over the past 1 month
  • 2% of all KALA investors are betting against KALA

KALA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -75.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-21.3191
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-7197900.0
Beta 1.16

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$7.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $7.4M

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.